Table 1.
The differences of postoperative clinical data between S1PR1 group and control group
Variables | S1PR1 | x 2 | p-Value | |
---|---|---|---|---|
– (%) | + (%) | |||
Age | ||||
<50 | 21 | 37 | 0.037 | 0.847 |
≥50 | 16 | 26 | ||
Tumor size | ||||
<3 | 14 | 23 | 0.018 | 0.894 |
≥3 | 23 | 40 | ||
Grade | ||||
I/II | 28 | 44 | 0.394 | 0.530 |
III | 9 | 19 | ||
TNM stage | ||||
I/II | 35 | 49 | 4.905 | 0.027 |
III/IV | 2 | 14 | ||
Lymphatic metastasis | ||||
No | 26 | 29 | 5.533 | 0.019 |
Yes | 11 | 34 | ||
Triple negative | ||||
No | 20 | 45 | 3.093 | 0.079 |
Yes | 17 | 18 | ||
VM | ||||
No | 26 | 58 | 8.237 | 0.004 |
Yes | 11 | 5 |
VM vasculogenic mimicry, S1PR1 sphingosine-1-phosphate receptor 1
*Statistically significant p < 0.05